
2021-03-27 00:57:02
Jinhushen Bio completes 67% acquisition with Tianjin Pharma, S shares offer price revised
Tianjin Zhong Xin Pharmaceutical Group says Jinhushen Biological Medical Science and Technology has completed its acquisition in its controlling shareholder, Tianjin Pharmaceutical Holdings (TPH) on March 26. Jinhushen, on Dec 19, 2020, entered into a sale and purchase agreement (SPA) with Tianjin B...